Track Sandu Pharmaceuticals Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: -2.65 %
Low
38.4
High
41.5
1 Month returns: -5.07 %
Low
37.3
High
42.0
1 Year returns: -15.76 %
Low
30.0
High
58.3
3 Year CAGR: -8.99 %
Low
30.0
High
85.0
5 Year CAGR: -7.73 %
Low
30.0
High
86.0
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Sandu Pharmaceuticals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Sandu Pharmaceuticals Ltd. Shareholding Pattern
Quarterly breakdown of Sandu Pharmaceuticals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Sandu Pharmaceuticals Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Sandu Pharmaceuticals Ltd.?
The current share price of Sandu Pharmaceuticals Ltd. is ₹ 39.30 as of 27 Jul 2026.
What is the market capitalisation of Sandu Pharmaceuticals Ltd.?
The market capitalisation of Sandu Pharmaceuticals Ltd. stands at ₹ 37.96 Cr.
What is the PE ratio of Sandu Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Sandu Pharmaceuticals Ltd. is 21.49 as of the latest trailing twelve months data.
What is the ROE and ROCE of Sandu Pharmaceuticals Ltd.?
Sandu Pharmaceuticals Ltd. has a Return on Equity (ROE) of 4.12% and a Return on Capital Employed (ROCE) of 5.37% as per the latest financial reports.
What is the 52-week high and low of Sandu Pharmaceuticals Ltd.?
The 52-week high of Sandu Pharmaceuticals Ltd. is - and the 52-week low is -.
What is the dividend yield of Sandu Pharmaceuticals Ltd.?
The dividend yield of Sandu Pharmaceuticals Ltd. is 2.04% based on the current market price.
What is the FII and DII holding in Sandu Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.01% and retail/public investors hold 38.88% of Sandu Pharmaceuticals Ltd. shares.
What sector does Sandu Pharmaceuticals Ltd. belong to?
Sandu Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Sandu Pharmaceuticals Ltd.?
The beta of Sandu Pharmaceuticals Ltd. is 0.64, indicating its price volatility relative to the broader market. Over the past 1 year, Sandu Pharmaceuticals Ltd. has delivered an absolute return of -20.63%.
What is the RSI of Sandu Pharmaceuticals Ltd.?
The 14-day Relative Strength Index (RSI) of Sandu Pharmaceuticals Ltd. is 41.77, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Sandu Pharmaceuticals Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
PE TTM of 21.49 indicates that the stock is reasonably valued on a standalone basis. Discount to industry median P/E is decent at -30.86%
What is P/E Ratio?
Median: 31.08
Value 21.49
-43.163369.02
Consistently pays dividend
The company has not missed dividend payments once in the last 4 financial years
What is Dividend streak?
Company is net cash
The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet
What is Net Debt ?
Negative
Not enough talking points with negative stance
Neutral
Moderate dividend yield
The company has a moderate dividend yield of 2.04%
What is Dividend yield?
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.00636601.
Company Profile
Overview of Sandu Pharmaceuticals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Sandu Pharmaceuticals Limited is an India-based company, which is mainly engaged in the business of manufacturing and trading of ayurvedic medicines under the brand name, SANDU. The Companys product category includes digestive health, immunity, muscle and bone health, respiratory health, wellness, and others. Its digestive health products focus on constipation, hyperacidity, indigestion and flatulence, and loose motions, among others. Its wellness products cover female wellness, male wellness and mother and child. Its respiratory health products focus on respiratory health, asthma, and cold and cough. Its ayurveda category includes herbs, panchakarma, dincharya, rutucharya, ahar vihar, arogyadarshika, prakruti and yoga. The Company also offers products, such as an immunity kit and a power herbs range. Its products are manufactured using in-house know-how supplied by Sandu Brothers Private Limited. The Companys products are sold through e-commerce marketplaces.
Sandu Pharmaceuticals Limited is an India-based company, which is mainly engaged in the business of manufacturing and trading of ayurvedic medicines under the brand name, SANDU. The Companys product category includes digestive health, immunity, muscle and bone health, respiratory health, wellness, a...
Key personnel
Mr. Vijay Kajrekar
Chief Financial Officer
Mrs. Pratika Prathamesh Mhambray
Compliance Officer, Company Secretary
Shri. Balram ViswanathanD
Executive Chairman of the Board, Managing Director